Matriptase is a member of an expanding group of type II transmembrane serine proteases. Recently, much has been learned about the biochemistry, cellular biology, normal tissue physiology, and human pathology of this protease, and of its inhibitor, termed the hepatocyte growth factor inhibitor-1 (HAI-1). This review examines the recent literature that has characterized the regulation of matriptase and HAI-1 with an emphasis on the molecular mechanisms governing its zymogen activation, inhibition by HAI-1, and ectodomain shedding.
Zymogen activation, inhibition, and ectodomain shedding of matriptase. Publishing Authors By Initials
Zymogen activation, inhibition, and ectodomain shedding of matriptase. Journal Published:
PUBLICATION TYPE: Review
Journal: Frontiers in bioscience : a journal and virtual li
VOLUME: 13
Page Numbers: 621-35
Journal Abbreviation: Front. Biosci.
ISSN: 1093-4715
DAY: 1
MONTH: 01
YEAR: 2008
Zymogen activation, inhibition, and ectodomain shedding of matriptase. Information
Number of References: 77
LANGUAGE: eng
NlmUniqueID: 9709506
Zymogen activation, inhibition, and ectodomain shedding of matriptase. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Zymogen activation, inhibition, and ectodomain shedding of matriptase. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Zymogen activation, inhibition, and ectodomain shedding of matriptase.
AFFILIATION: Department of Biochemistry and Molecular Biology, Greenborne Cancer Center, University of Maryland, School of Medicine, Baltimore, MD 21201, USA. cylin@som.umaryland
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Front Biosci
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Zymogen activation, inhibition, and ectodomain shedding of matriptase Related Publications